ImmuCell Corporation AMENDMENT TO RIGHTS AGREEMENTRights Agreement • August 10th, 2023 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances
THIS AMENDMENT is entered into as of August 9, 2023, between IMMUCELL CORPORATION, a Delaware corporation (the “Company”), and Equiniti Trust Company, LLC., a New York corporation, as Rights Agent (the “Rights Agent”).
